What is different about the medicines?
Semaglutide targets GLP-1 receptors; tirzepatide targets GIP and GLP-1 receptors. That mechanistic distinction is useful context, but it cannot determine the right prescription for an individual.
What needs a clinician’s judgment?
Medical history, other medications, treatment goals, contraindications and tolerability belong in the clinical discussion. We do not convert study averages or provider marketing into a personalized prediction, dose recommendation or switching plan.
What can you compare as a buyer?
You can compare the exact branded or compounded product, care fee, pharmacy cost, insurance process and payment commitment. Keep each quote tied to a named product and supply period.
The fair comparison
Do not place an introductory compounded offer beside a recurring approved-brand price and call the difference a saving on equivalent care. Ask what the price includes and what evidence applies to each product.
Sources and scope
Read FDA’s guidance on unapproved GLP-1 drugs for product-status context. For clinical product information, use semaglutide labeling and tirzepatide labeling. This guide explains comparison questions; it is not a clinical treatment recommendation.